569 related articles for article (PubMed ID: 16040409)
21. Calcipotriol-betamethasone ointment versus calcipotriol ointment in the treatment of psoriasis vulgaris.
Duweb G; Alhaddar J; Elsherif B; Eljehawi N; Makhlouf H
Drugs Exp Clin Res; 2005; 31(5-6):175-9. PubMed ID: 16425973
[TBL] [Abstract][Full Text] [Related]
22. A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris.
Torras H; Aliaga A; López-Estebaranz JL; Hernández I; Gardeazabal J; Quintanilla E; Mascaró JM
J Dermatolog Treat; 2004 Apr; 15(2):98-103. PubMed ID: 15204160
[TBL] [Abstract][Full Text] [Related]
23. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
Leyden J; Thiboutot DM; Shalita AR; Webster G; Washenik K; Strober BE; Shupack J
Arch Dermatol; 2006 May; 142(5):605-12. PubMed ID: 16702498
[TBL] [Abstract][Full Text] [Related]
24. Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.
Saraceno R; Andreassi L; Ayala F; Bongiorno MR; Giannetti A; Lisi P; Martini P; Peris K; Peserico A; Chimenti S
J Dermatolog Treat; 2007; 18(6):361-5. PubMed ID: 17934937
[TBL] [Abstract][Full Text] [Related]
25. Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.
Lebwohl M; Ast E; Callen JP; Cullen SI; Hong SR; Kulp-Shorten CL; Lowe NJ; Phillips TJ; Rosen T; Wolf DI; Quell JM; Sefton J; Lue JC; Gibson JR; Chandraratna RA
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):705-11. PubMed ID: 9591815
[TBL] [Abstract][Full Text] [Related]
26. Occlusive versus nonocclusive calcipotriol ointment treatment for palmoplantar psoriasis.
Duweb GA; Abuzariba O; Rahim M; al-Taweel M; al-Alem S; Abdulla SA
Int J Tissue React; 2001; 23(2):59-62. PubMed ID: 11447774
[TBL] [Abstract][Full Text] [Related]
27. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
van de Kerkhof PC
Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
[TBL] [Abstract][Full Text] [Related]
28. 0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study.
Ortonne JP; van de Kerkhof PC; Prinz JC; Bieber T; Lahfa M; Rubins A; Wozel G; Lorette G;
Acta Derm Venereol; 2006; 86(1):29-33. PubMed ID: 16585986
[TBL] [Abstract][Full Text] [Related]
29. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris.
Darley CR; Cunliffe WJ; Green CM; Hutchinson PE; Klaber MR; Downes N
Br J Dermatol; 1996 Sep; 135(3):390-3. PubMed ID: 8949431
[TBL] [Abstract][Full Text] [Related]
31. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Tanghetti E; Dhawan S; Torok H; Kircik L
Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
[TBL] [Abstract][Full Text] [Related]
32. Topical calcipotriol (MC 903) for psoriasis: a clinical study.
Mozzanica N; Cattaneo A; Schmitt E; Legori A; Finzi AF
Acta Derm Venereol Suppl (Stockh); 1994; 186():169-70. PubMed ID: 8073826
[TBL] [Abstract][Full Text] [Related]
33. Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study.
Kragballe K; Fogh K; Søgaard H
Acta Derm Venereol; 1991; 71(6):475-8. PubMed ID: 1685828
[TBL] [Abstract][Full Text] [Related]
34. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis.
Schiener R; Behrens-Williams SC; Pillekamp H; Kaskel P; Peter RU; Kerscher M
Br J Dermatol; 2000 Dec; 143(6):1275-8. PubMed ID: 11122033
[TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of topical calcipotriol versus coal tar and salicylic acid ointment in chronic plaque psoriasis.
Singh P; Gupta S; Abidi A; Krishna A
J Drugs Dermatol; 2013 Aug; 12(8):868-73. PubMed ID: 23986159
[TBL] [Abstract][Full Text] [Related]
36. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
Liao YH; Chiu HC; Tseng YS; Tsai TF
Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
[TBL] [Abstract][Full Text] [Related]
37. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
Rigopoulos D; Gregoriou S; Daniel Iii CR; Belyayeva H; Larios G; Verra P; Stamou C; Kontochristopoulos G; Avgerinou G; Katsambas A
Dermatology; 2009; 218(4):338-41. PubMed ID: 19212110
[TBL] [Abstract][Full Text] [Related]
38. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K; Austad J; Barnes L; Bibby A; de la Brassinne M; Cambazard F; Fleming C; Heikkilä H; Jolliffe D; Peyri J; Svensson A; Toole J; Wozel G
Br J Dermatol; 2006 Jun; 154(6):1155-60. PubMed ID: 16704648
[TBL] [Abstract][Full Text] [Related]
39. Psoriasis vulgaris: once-versus twice-daily application of calcipotriol cream.
Duweb G; Alhaddar J; Abuhamida M
Int J Tissue React; 2005; 27(4):155-8. PubMed ID: 16440578
[TBL] [Abstract][Full Text] [Related]
40. Short contact therapy with tazarotene in psoriasis vulgaris.
Veraldi S; Caputo R; Pacifico A; Peris K; Soda R; Chimenti S
Dermatology; 2006; 212(3):235-7. PubMed ID: 16549919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]